CREB3 and hepatocellular carcinoma: Immunohistochemistry (IHC) analysis for two HCC tissue microarrays (TMAs) (Tongji cohort 1 and Tongji cohort 2) showed that the in situ protein level of CREB3 was lower in HCCs compared with peritumoral tissues (Figure 1D).